Vascular endothelial growth factor +936C/T polymorphism and breast cancer risk: A meta-analysis of 13 case-control studies

Tumor Biology

Volumn 35, Issue 3, 2014, Pages 2687-2692

  Yan, Yulan ^a   Liang, Hongjie ^a   Li, Taijie ^a   Guo, Shihui ^a   Li, Meng ^a   Li, Shan ^a   Qin, Xue ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Meta analysis; Polymorphism; VEGF

Indexed keywords

VASCULOTROPIN;

ARTICLE; ASIAN; BREAST CANCER; CANCER RISK; CAUCASIAN; DNA POLYMORPHISM; EMBASE; ETHNICITY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MEDICAL LITERATURE; MEDLINE; POLYMERASE CHAIN REACTION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PUBLISHING; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SYSTEMATIC REVIEW; TUMOR GENE; VASCULAR ENDOTHELIAL GROWTH FACTOR GENE;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84899064060     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1354-2     Document Type: Article

References (41)

1. Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res. 2004;6:229-39.
2. Sturgeon SR, Schairer C, Grauman D, El Ghormli L, Devesa S. Trends in breast cancer mortality rates by region of the United States, 1950-1999. Cancer Causes Control. 2004;15:987-95.
3. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
4. Meteoglu I, Dikicioglu E, Erkus M, Culhaci N, Kacar F, Ozkara E, et al. Breast carcinogenesis. Transition from hyperplasia to invasive lesions. Saudi Med J. 2005;26:1889-96.
5. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52:6735-40.
6. O'Brien JM. Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland, by P. Lichtenstein, N.V. Holm, P.K. Verkasalo, A. Iliadou, J. Kaprio, M. Koskenvuo, E. Pukkala, A. Skytthe, and K. Hemminki. N Engl J Med 343:78-84, 2000. Surv Ophthalmol 2000;45:167-168.
7. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343:78-85.
8. Nathanson KL, Wooster R, Weber BL. Breast cancer genetics: what we know and what we need. Nat Med. 2001;7:552-6.
9. Balmain A, Gray J, Ponder B. The genetics and genomics of cancer. Nat Genet. 2003;33(Suppl):238-44.
10. Hu Z, Li X, Yuan R, Ring BZ, Su L. Three common tp53 polymorphisms in susceptibility to breast cancer, evidence from meta-analysis. Breast Cancer Res Treat. 2010;120:705-14.
11. Qiu LX, Yao L, Zhang J, Zhu XD, Zhao XM, Xue K, et al. Xpd lys751gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects. Breast Cancer Res Treat. 2010;124:229-35.
12. Ferrara N. Vegf and the quest for tumour angiogenesis factors. Nat Rev Cancer. 2002;2:795-803.
13. Stevens A, Soden J, Brenchley PE, Ralph S, Ray DW. Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res. 2003;63:812-6.
14. Chae YS, Kim JG, Sohn SK, Cho YY, Moon JH, Bae HI, et al. Investigation of vascular endothelial growth factor gene polymorphisms and its association with clinicopathologic characteristics in gastric cancer. Oncology. 2006;71:266-72.
15. Dassoulas K, Gazouli M, Rizos S, Theodoropoulos G, Christoni Z, Nikiteas N, et al. Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Mol Carcinog. 2009;48:563-9.
16. Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E. A common 936 c/t mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res. 2000;37:443-8.
17. Qiu LX, Wang K, Yang S, Mao C, Zhao L, Yao L, et al. Current evidences on vascular endothelial growth factor polymorphisms and breast cancer susceptibility. Mol Biol Rep. 2011;38:4491-4.
18. 18F-fluorodeoxyglucose uptake. Breast Cancer Res Treat. 2004;88:205-8.
19. Luo T, Chen L, He P, Hu QC, Zhong XR, Sun Y, et al. Vascular endothelial growth factor (vegf) gene polymorphisms and breast cancer risk in a chinese population. Asian Pac J Cancer Prev. 2013;14:2433-7.
20. Rodrigues P, Furriol J, Tormo E, Ballester S, Lluch A, Eroles P. The single-nucleotide polymorphisms +936 c/t vegf and -710 c/t vegfr1 are associated with breast cancer protection in a Spanish population. Breast Cancer Res Treat. 2012;133:769-78.
21. Absenger G, Szkandera J, Stotz M, Pichler M, Winder T, Langsenlehner T, et al. A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early-stage breast cancer. Mol Carcinog 2013
22. Oliveira C, Lourenco GJ, Silva PM, Cardoso-Filho C, Favarelli MH, Goncales NS, et al. Polymorphisms in the 5'- and 3'-untranslated region of the vegf gene and sporadic breast cancer risk and clinicopathologic characteristics. Tumour Biol. 2011;32:295-300.
23. Jakubowska A, Gronwald J, Menkiszak J, Gorski B, Huzarski T, Byrski T, et al. The VEGF-936-C > T 3'UTR polymorphism reduces BRCA1-associated breast cancer risk in Polish women. Cancer Lett. 2008;262:71-6.
24. Balasubramanian SP, Cox A, Cross SS, Higham SE, Brown NJ, Reed MW. Influence of vegf-a gene variation and protein levels in breast cancer susceptibility and severity. Int J Cancer. 2007;121:1009-16.
25. Kataoka N, Cai Q, Wen W, Shu XO, Jin F, Gao YT, et al. Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women. Cancer Epidemiol Biomarkers Prev. 2006;15:1148-52.
26. Jacobs EJ, Feigelson HS, Bain EB, Brady KA, Rodriguez C, Stevens VL, et al. Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort. Breast Cancer Res. 2006;8:R22.
27. Jin Q, Hemminki K, Enquist K, Lenner P, Grzybowska E, Klaes R, et al. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res. 2005;11:3647-53.
28. Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, et al. A common 936 c/t gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer. 2003;106:468-71.
29. Lin GT, Tseng HF, Yang CH, Hou MF, Chuang LY, Tai HT, et al. Combinational polymorphisms of seven CXCL12-related genes are protective against breast cancer in Taiwan. OMICS. 2009;13:165-72.
30. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539-58.
31. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-48.
32. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88.
33. Zamora-Ros R, Rothwell JA, Scalbert A, Knaze V, Romieu I, Slimani N, et al. Dietary intakes and food sources of phenolic acids in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Br J Nutr 2013:1-12.
34. Tobias A, Campbell MJ. Modelling influenza epidemics in the relation between black smoke and total mortality. A sensitivity analysis. J Epidemiol Community Health. 1999;53:583-4.
35. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-34.
36. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-101.
37. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407:249-57.
38. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004;25:581-611.
39. Hu YF, Luscher B, Admon A, Mermod N, Tjian R. Transcription factor ap-4 contains multiple dimerization domains that regulate dimer specificity. Genes Dev. 1990;4:1741-52.
40. Mermod N, Williams TJ, Tjian R. Enhancer binding factors ap-4 and ap-1 act in concert to activate sv40 late transcription in vitro. Nature. 1988;332:557-61.
41. Yang DS, Park KH, Woo OH, Woo SU, Kim AR, Lee ES, et al. Association of a vascular endothelial growth factor gene 936 c/t polymorphism with breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2011;125:849-53.